tradingkey.logo
tradingkey.logo
Search

Cytosorbents Corp

CTSO
Add to Watchlist
0.361USD
+0.011+3.08%
Close 07-31 16:00ETQuotes delayed by 15 min
22.68MMarket Cap
LossP/E TTM

CTSO Financials

See Cytosorbents Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cytosorbents Corp Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.05
Revenue / Forecast
--/9.35M
Period
FY2025 Earnings
Revenue(YoY)
37.06M
4.13%
EPS(YoY)
-0.13
65.39%
Analyst Rating
HOLD
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-235.87%-0.08
39.26%-0.09
-17.85%-0.05
139.33%0.03
78.24%-0.02
-2.03%-0.14
79.31%-0.04
43.44%-0.08
33.32%-0.11
-704.21%-0.14
---0.21
---0.14
---0.17
---0.02
---0.74
----
----
----
----
----
Revenue
1.57%8.86M
41.56%9.23M
1.01%9.48M
-2.81%9.62M
-2.92%8.73M
91.65%6.52M
6.58%9.39M
5.03%9.89M
-4.87%8.99M
-63.75%3.40M
8.62%8.81M
10.89%9.42M
8.72%9.45M
-12.91%9.39M
-16.90%8.11M
-29.35%8.50M
-18.00%8.69M
-9.82%10.78M
-7.45%9.76M
22.76%12.02M
Net Profit
-246.94%-5.13M
30.28%-5.50M
-35.81%-3.17M
146.99%1.95M
75.72%-1.48M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
16.89%-6.09M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
91.77%-766.13K
-90.45%-12.20M
-132.58%-10.88M
-115.13%-8.97M
-1273.27%-9.31M
-662.90%-6.41M
-63.15%-4.68M
Net Margin
-241.59%-57.86%
50.74%-59.53%
-34.46%-33.42%
141.69%20.25%
74.99%-16.94%
37.43%-120.86%
76.18%-24.86%
25.65%-48.56%
12.64%-67.73%
-2267.41%-193.15%
---104.34%
---65.31%
---77.53%
---8.16%
---126.67%
----
----
----
----
----
Gross Margin
-2.77%69.16%
-29.01%73.68%
24.95%70.28%
-3.66%70.85%
-6.98%71.13%
-27.49%103.80%
-11.61%56.24%
15.12%73.55%
32.45%76.46%
133.49%143.15%
--63.64%
--63.89%
--57.73%
--61.31%
--59.20%
----
----
----
----
----
Debt to assets ratio
49.66%41.81%
27.68%37.72%
10.25%31.84%
17.06%29.96%
196.93%27.94%
210.27%29.55%
173.04%28.88%
167.29%25.59%
7.90%9.41%
20.43%9.52%
--10.58%
--9.57%
--8.72%
--7.91%
----
----
----
----
----
----
Revenue
1.57%8.86M
41.56%9.23M
1.01%9.48M
-2.81%9.62M
-2.92%8.73M
91.65%6.52M
6.58%9.39M
5.03%9.89M
-4.87%8.99M
-63.75%3.40M
8.62%8.81M
10.89%9.42M
8.72%9.45M
-12.91%9.39M
-16.90%8.11M
-29.35%8.50M
-18.00%8.69M
-9.82%10.78M
-7.45%9.76M
22.76%12.02M
Operating profit
21.69%-3.04M
13.66%-3.48M
38.55%-2.66M
-11.79%-3.62M
16.52%-3.89M
59.35%-4.02M
39.55%-4.33M
50.54%-3.23M
40.15%-4.66M
-79.52%-9.90M
20.52%-7.17M
20.57%-6.54M
-3.95%-7.78M
42.32%-5.52M
-66.80%-9.02M
-67.14%-8.23M
-162.43%-7.49M
-262.98%-9.56M
-175.87%-5.41M
-49.34%-4.92M
Net Profit
-246.94%-5.13M
30.28%-5.50M
-35.81%-3.17M
146.99%1.95M
75.72%-1.48M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
16.89%-6.09M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
91.77%-766.13K
-90.45%-12.20M
-132.58%-10.88M
-115.13%-8.97M
-1273.27%-9.31M
-662.90%-6.41M
-63.15%-4.68M
Current assets
-30.13%17.76M
-4.49%20.63M
28.41%21.31M
4.70%22.99M
27.11%25.41M
-14.94%21.60M
-13.83%16.60M
-7.14%21.96M
-29.02%19.99M
-24.77%25.40M
-40.52%19.26M
-43.23%23.64M
-49.57%28.16M
-47.50%33.76M
-55.49%32.38M
-45.97%41.65M
-29.86%55.85M
-22.02%64.30M
-24.85%72.75M
83.76%77.08M
Total current liabilities
67.45%16.30M
-1.17%9.71M
19.95%10.11M
-4.78%9.84M
-27.47%9.74M
-30.00%9.82M
-29.59%8.43M
-0.14%10.34M
28.63%13.42M
44.48%14.04M
18.32%11.97M
-1.92%10.35M
-28.87%10.44M
-29.04%9.71M
-8.60%10.12M
-2.24%10.55M
50.34%14.67M
34.84%13.69M
-36.22%11.07M
-31.08%10.80M
Total assets
-20.12%40.56M
-6.73%44.18M
-4.30%45.75M
-10.18%47.99M
7.88%50.78M
-10.55%47.37M
0.48%47.80M
1.87%53.43M
-18.09%47.07M
-16.25%52.96M
-23.60%47.58M
-26.35%52.44M
-30.99%57.46M
-29.37%63.23M
-34.50%62.27M
-27.48%71.21M
-4.81%83.27M
-0.48%89.52M
-8.84%95.07M
99.34%98.19M
Total liabilities
5.88%38.37M
5.55%38.28M
5.53%36.73M
-0.78%36.40M
28.77%36.24M
23.03%36.26M
19.76%34.80M
29.42%36.69M
-1.28%28.14M
5.81%29.48M
25.66%29.06M
19.90%28.35M
2.38%28.51M
3.40%27.86M
-5.43%23.13M
-0.68%23.65M
172.44%27.84M
150.97%26.94M
1.69%24.46M
-4.52%23.81M
Total equity
-84.91%2.19M
-46.85%5.90M
-30.61%9.02M
-30.77%11.59M
-23.17%14.54M
-52.70%11.11M
-29.78%13.00M
-30.54%16.74M
-34.63%18.93M
-33.62%23.48M
-52.71%18.51M
-49.34%24.09M
-47.76%28.96M
-43.47%35.37M
-44.57%39.14M
-36.06%47.56M
-28.26%55.43M
-21.00%62.58M
-11.99%70.61M
205.83%74.38M
Net operating income
66.46%-1.16M
-106.01%-4.83M
-4.70%-2.58M
68.51%-1.51M
28.26%-3.46M
63.45%-2.34M
52.73%-2.46M
30.85%-4.79M
-55.39%-4.83M
-19.98%-6.41M
22.70%-5.21M
13.77%-6.93M
61.72%-3.11M
2.75%-5.34M
-62.93%-6.73M
-294.84%-8.04M
-246.35%-8.12M
-419.15%-5.49M
-25.86%-4.13M
-205.06%-2.04M
Net investment
2.63%-46.00K
-134.31%-291.00K
118.43%55.00K
-9.92%-131.76K
62.81%-47.24K
8.63%-124.19K
-15.77%-298.35K
-185.44%-119.86K
81.40%-127.02K
34.04%-135.92K
64.03%-257.72K
102.99%140.28K
19.47%-682.88K
87.68%-206.08K
29.58%-716.53K
-375.79%-4.69M
-39.85%-847.96K
-528.53%-1.67M
-151.75%-1.02M
-97.98%-984.68K
Net financing
-100.00%0.00
1385.08%2.48M
100.00%0.00
-100.01%-1.13K
1294.93%6.83M
-98.63%166.86K
-115.27%-99.03K
956.22%9.83M
-183.56%-571.76K
144.21%12.21M
--648.32K
--931.12K
1795.49%684.28K
6278.64%5.00M
-100.00%0.00
-100.00%0.00
-152.72%-40.36K
99.47%-80.92K
-98.95%589.72K
-98.20%129.85K

FAQs

What is the total revenue of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total revenue reached 37.06M, with a year-on-year change of 35.59M.

What are the current assets of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its current assets were 20.63M, with a year-on-year change of -4.49.

What are the total assets of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total assets of Cytosorbents Corp were 44.18M, with a year-on-year change of -6.73.

What are the total liabilities of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total liabilities of Cytosorbents Corp were 38.28M, with a year-on-year change of 5.55.

What is the total equity of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total equity of Cytosorbents Corp was 5.90M, with a year-on-year change of -46.85.

What is the net operating income of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net operating income of Cytosorbents Corp was -13.64M, with a year-on-year change of 17.10.

What is the net investment of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net investment of Cytosorbents Corp was -415.00K, with a year-on-year change of 38.01.

What is the net financing of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net financing of Cytosorbents Corp was 9.31M, with a year-on-year change of -0.23.

What is the Earnings Per Share (EPS) of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.13, with a year-on-year change of 65.39.

What is the net income of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net income was -8.20M, with a year-on-year change of 60.43.

What is the net margin of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net profit margin was -22.12, with a year-on-year change of 62.00.

What is the gross margin of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its gross margin was 71.48, with a year-on-year change of 1.26.

What is the debt-to-asset ratio of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its debt-to-asset ratio was 37.72, with a year-on-year change of 27.68.

What is the Return on Equity (ROE) of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its Return on Equity (ROE) was -96.39, with a year-on-year change of 19.54.

What is the Return on Assets (ROA) of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its Return on Assets (ROA) was -17.91, with a year-on-year change of 56.64.

What is the operating profit of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its operating profit was -13.64M, with a year-on-year change of 17.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.